|Articles|November 8, 2016
myClin Selected for LLS Clinical Trial
The Leukemia & Lymphoma Society (LLS) has selected myClin for its Acute Myeloid Leukemia (AML) clinical trial.
Advertisement
The Leukemia & Lymphoma Society (LLS) has selected myClin for its Acute Myeloid Leukemia (AML) clinical trial. The myClin Clinical Trial Knowledge Platform will assist clinical study entities by streamlining communication to share study documents.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Operational Pragmatism in ePRO-heavy trials
2
Why Regulator-Sponsor Alignment Is Critical to Modernizing Trial Execution
3
Could Selective Safety Data Collection Become the Industry's New Default?
4
ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models
5